These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Immunoreactivity of individuals in heterogenous populations and immunoprophylaxis of infectious diseases]. Sokhin AA Vestn Akad Med Nauk SSSR; 1983; (5):60-4. PubMed ID: 6868806 [No Abstract] [Full Text] [Related]
23. Reflections on getting ahead of the curve--an infectious disease epidemiologist's view of the past and the present. Noah N Commun Dis Public Health; 2002 Jun; 5(2):94-6. PubMed ID: 12166315 [No Abstract] [Full Text] [Related]
24. Infectious diseases. Stoeckle M; Douglas RG JAMA; 1995 Jun; 273(21):1686-8. PubMed ID: 7752417 [TBL] [Abstract][Full Text] [Related]
25. Synthetic vaccines for infectious and autoimmune diseases. Sela M Adv Exp Med Biol; 1996; 397():1-5. PubMed ID: 8718575 [No Abstract] [Full Text] [Related]
26. Infectious disease challenges in the 1990's. Opal SM Med Health R I; 1996 Mar; 79(3):100-9. PubMed ID: 8901290 [No Abstract] [Full Text] [Related]
27. Bioterror, agroterror, and new diseases. Ambrus JL; Ambrus CM; Ambrus JL; Akhter S; Zaidi S; Rohilla R; Baig MS Discov Med; 2007 Jun; 7(38):82-7. PubMed ID: 18093470 [TBL] [Abstract][Full Text] [Related]
28. PHLS overview of communicable diseases 1997: results of a priority setting exercise. Rushdy A; O'Mahony M Commun Dis Rep CDR Suppl; 1998 Nov; 8(5):S1-12. PubMed ID: 9830790 [TBL] [Abstract][Full Text] [Related]
36. Control of vector-borne infectious diseases by human immunity against α-Gal. Cabezas Cruz A; Valdés JJ; de la Fuente J Expert Rev Vaccines; 2016 Aug; 15(8):953-5. PubMed ID: 27100121 [No Abstract] [Full Text] [Related]
39. The Sir Mark Oliphant Conferences: international frontiers of science and technology. Belz GT; De Groot A Hum Vaccin; 2008; 4(4):260-1. PubMed ID: 18682691 [TBL] [Abstract][Full Text] [Related]